Keyword: "women"

20 items were found with the keyword "women".

  • LowSalt4Life

    PI: Mike Dorsch , Scott Hummel MD MS

    High dietary sodium intake is linked to incident hypertension, stroke, heart failure and kidney disease. U.S. federal guidelines advocate daily sodium intake of less than 2,300 milligrams (mg) with further reduction to 1,500 mg in persons who are 51 and older and those of any age who are African American and/or have hypertension, diabetes, or chronic kidney disease. The estimated average sodium intake for Americans is 3,400 mg per day. In recent years, consumption of pre-processed and restaurant foods has substantially increased, and more than 75% of sodium in the average U.S. diet now comes from these sources. The important gap is that most patients prescribed a low sodium diet either do not understand or have information about the sodium content of the foods they eat, and current IT approaches to reduce sodium intake focus solely on counting the amount of dietary sodium eaten. Therefore, there is a critical need to develop technologies that provide just-in-time information about low sodium choices in both grocery stores and restaurants with an overall goal to improve the ability to reduce dietary sodium intake. LowSalt4Life is an app designed to provide education, assistance, and support to people who are trying to reduce their sodium intake. It includes actionable push messages to promote adherence to a low sodium diet, and was developed using information derived from focus groups. The goal is to demonstrate the effectiveness of the mobile application in reducing sodium intake in participants with hypertension.   (08/01/2016 - 08/01/2019)

  • MiMove: Knee Rehabilitation

    New

    PI: Cathleen M. Connell, PhD , Susan A. Murphy, PhD , Maratt

    MiMove: optimizing the transition to home after knee replacement surgery.  (05/01/2016 - 12/31/2016)

  • My GI Health - Virtual Dietician with Low FODMAP diet

    PI: William D. Chey, MD

    This program educates GI patients about a low FODMAP diet in an engaging, animation- and voice-based interface. Patients learn about what FODMAPs are, what they do in the body, how to eliminate them from the diet, and how to challenge each FODMAP group to find their triggers. (FODMAP is an acronym: Fermentable Oligosaccharides, Disaccharides, Monosaccharides and Polyols. These are fermentable sugars that some cause GI symptoms in some people.) (12/01/2013 - 12/01/2016)

  • CanSORT - CancerDoctorsLikeMe

    New

    PI: Lawrence C. An, MD , Sarah T. Hawley, PhD, MPH , Kenneth A. Resnicow, PhD

    The goals of the study are to collect pilot data on provider-patient interactions around contralateral prophylactic mastectomy (CPM) for breast cancer surgeons and risk of recurrence for medical oncologists. We used a web intervention to present population-based data and patient-centered communication techniques to doctors.  (07/01/2012 - 08/31/2017)

  • I Can Decide

    PI: Sarah T. Hawley, PhD, MPH

    Patients newly diagnosed with breast cancer face a series of complex decisions regarding locoreginal and systemic treatment. Currently many of these decisions do not meet the definition of a high quality decision, defined as one that is both informed (based on an accurate understanding of the treatment risks and benefits) and preference-concordant (consistent with the patient's underlying preferences). I Can Decide evaluates the impact of an innovative decision tool on locoregional and systemic therapy decision making for newly diagnosed breast cancer patients. (07/01/2012 - 08/31/2017)

    Related Media:

  • A Population-Based Approach to Survivorship Care: Delivering Interventions via the Web

    PI: Jennifer J. Griggs, MD, MPH

    This is a prospective study in a population-based sample of patients treated in diverse clinical settings. Participant surveys, SEER registry data, and data on use of the web portal is combined into a single dataset to address the aims and hypotheses proposed above. Our primary goal is to assess the feasibility of recruiting patients to a web-based intervention. Patient participants are invited to complete a survey and then to use the web portal for 4 months. A brief evaluation of the portal by the patient participants will follow. Portal non-users or low users (one visit only) will also be surveyed and invited to provide information on why they did not visit or use the portal. (10/01/2011 - 09/30/2012)

  • Me First

    PI: Vanessa K Dalton, MD, MPH , Ruth C. Carlos, MD

    MeFirst aims to develop and refine a tailored risk communication intervention to improve HPV vaccination uptake in young adult women ages 18-26 when administered during a teachable moment. The teachable moment is a spontaneously occurring health event that serves as a natural educational gateway. The potential effects of this intervention on HPV vaccine utilization in a hard-to-reach age group enhances system-based interventions that can be more broadly applied or generalized to other health interventions targeted to young adults or other health settings. (07/01/2010 - 06/30/2011)

  • Vax Facts

    PI: Amanda F. Dempsey, MD, PhD, MPH

    Vax Facts offers a tailored brochure to address parents' concerns about HPV vaccines. The intervention draws on our previous data on reasons parents decline HPV vaccines for their daughters. This data is used to develop questions and responses that elicit and address parental beliefs that hinder HPV vaccine series initiation. Intervention messages are tailored to address these beliefs and concerns. (01/01/2010 - 12/31/2010)

  • Breast Cancer Genetics Usability Test

    PI: J. Scott Roberts, PhD

    The purpose of this project is to develop and test a web-delivered, tailored decision aid for women at risk for breast and ovarian cancer. Existing educational materials are refined then offered in an interactive website featuring greater personalization of risk information, using validated risk communication techniques in a patient-friendly Web-based application.Such technologies are needed to expand the reach and improve the cost- effectiveness of breast cancer genetic services and are part of a growing movement within clinical care to provide validated patient decision aids. (03/01/2009 - 02/28/2010)

  • Survivorship Resource Room

    PI: Jennifer J. Griggs, MD, MPH

    Breast cancer survivors often experience challenges as they transition from treatment to survivorship. The Survivorship Resource Room offers informational, emotional, and instrumental support during this transition. (09/01/2008 - 08/31/2010)

  • CECCR2 - Center of Excellence In Cancer Communications Research II

    PI: Victor J. Strecher, PhD, MPH

    The purpose of the University of Michigan Center of Excellence in Cancer Communications Research (CECCR) is to develop an efficient, theory-driven model for generating tailored health behavior interventions for many health behaviors and socio-demographic populations. (09/01/2008 - 08/31/2013)

  • Breast Cancer Patient Educational Tool

    PI: Sarah T. Hawley, PhD, MPH

    For the past decade there has been debate around whether mastectomy or breast conserving surgery (BCS) with radiation is the "best" treatment for early stage breast cancer. The goal of this study is to develop and pilot test an interactive computer-based decision tool for improving patient knowledge about breast cancer treatment, and help elicit patients' preferences for treatment characteristics. (09/20/2007 - 08/31/2009)

  • Breast Cancer Genetics Network Website Improvements

    PI: J. Scott Roberts, PhD

    This study refines an existing Web-based, tailored decision aid for women at risk for breast and ovarian cancer. The existing educational materials are made more interactive, more highly tailored and personalized. (09/01/2007 - 08/31/2008)

  • CECCR - Center of Excellence in Cancer Communications Research

    PI: Victor J. Strecher, PhD, MPH

    The purpose of the University of Michigan Center of Excellence in Cancer Communications Research (CECCR) is to develop an efficient, theory-driven model for generating tailored health behavior interventions that is generalizable across health behaviors and socio-demographic populations. (09/01/2003 - 08/31/2008)

  • Guide to Decide

    PI: Victor J. Strecher, PhD, MPH , Angela Fagerlin, PhD , Peter A. Ubel, MD

    Guide to Decide uses a multi-phased experimental process to explore methods of communicating risk regarding tamoxifen or raloxifene prophylaxis to women at high risk for breast cancer. (07/01/2003 - 08/31/2008)

  • Breast Cancer Informed Consent

    PI: E. J. Siegl, MA, OCN, RN

    This project aims to create an updated, user-friendly information booklet about breast cancer treatment options. The booklet, "Breast Cancer: What you need to know before treatment" is out of date and text heavy. Based on the Public Act 195 of 1986 that requires physicians to distribute this booklet to newly diagnosed breast cancer patients, it is necessary to update the booklet to reflect the current state of treatment options to help each person make the best treatment choice for themselves. *NOTE: The booklet was used for many years by the Michigan Department of Community Health, but is now out of circulation and not available to the public anymore. (03/01/2003 - 06/30/2003)

  • Cancer and Genetics

    PI: Sofia D. Merajver, MD, PhD

    Due to the complexity of information surrounding BRCA1/2 counseling and testing and its time consuming nature, efforts to facilitate the genetic counseling and education process are needed. This project aims to develop a flip book, CD-ROM, and website for use by genetics counselors with their patients covering the topics: basic genetics, cancer and genetics, genes associated with breast cancer, genetics testing, and managing cancer risk. (04/01/1997 - 07/30/1998)

  • Quit for Keeps

    PI: Victor J. Strecher, PhD, MPH

    The Quit for Keeps project (part of a cluster of ten projects called Smoke-Free Families) is a study designed to test the efficacy of using custom-tailored messages in convincing pregnant women to quit smoking. (11/01/1995 - 10/31/1998)

  • I Can Decide Dashboard

    New

    PI: Lawrence C. An, MD , Sarah T. Hawley, PhD, MPH

    Patients newly diagnosed with breast cancer face a series of complex decisions regarding locoreginal and systemic treatment. Currently many of these decisions do not meet the definition of a high quality decision, defined as one that is both informed (based on an accurate understanding of the treatment risks and benefits) and preference-concordant (consistent with the patient's underlying preferences). I Can Decide evaluates the impact of an innovative decision tool on locoregional and systemic therapy decision making for newly diagnosed breast cancer patients.  The I Can Decide Dashboard links the I Can Decide patient website to a clinic dashboard. Some of the information patients enter on the website will be shared with the clinic. The goal is to improve communication and help patients make informed treatment decisions. (08/31/2017)